Are my patients with rheumatic diseases at higher risk of COVID-19?

Ann Rheum Dis. 2020 Jun;79(6):839-840. doi: 10.1136/annrheumdis-2020-217322. Epub 2020 Mar 22.
No abstract available

Keywords: DMARDs (biologic); DMARDs (synthetic); autoimmune diseases; epidemiology; infections.

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Antirheumatic Agents*
  • Arthritis, Rheumatoid*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Pandemics
  • Pneumonia, Viral
  • Rheumatic Diseases*
  • SARS-CoV-2
  • Vaccination

Substances

  • Antirheumatic Agents